Navigating the Complexity of PAH: Advances in the Diagnosis and Management – Part III: Latest Data on PAH Treatment Approaches
Pulmonary arterial hypertension (PAH) is a complex and heterogenous disease, which remains challenging to diagnose and treat.
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Navigating the Complexity of PAH: Advances in the Diagnosis and Management – Part IV: Patient Cases: Putting Evidence Into Perspective
Pulmonary arterial hypertension (PAH) is a complex and heterogenous disease, which remains challenging to diagnose and treat.
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Webcast: Improving Renal Outcomes in Diabetic Kidney Disease - Interpreting Recent Evidence with Novel MRAs
During this activity, experts will discuss the rationale and clinical trial data for the use of non-steroidal mineralocorticoid receptor antagonists (MRAs) in patients with diabetic kidney disease (DKD), as well as the interpretation of these data and their potential application to patient care.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
The Challenge of Slowing Diabetic Kidney Disease Progression and Reducing Cardiovascular Risk: Recent Advances and Novel Strategies
Diabetic kidney disease (DKD) remains one of the major causes of morbidity and mortality in patients with type 2 diabetes. Despite optimized glycemic control and renin-angiotensin-aldosterone system (RAAS) inhibitor therapy, many patients with DKD progress to kidney failure.
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Virtual Symposium: Antithrombotic Therapy for Symptomatic PAD: Interpreting the Evidence and Recent Advances
Patients with diabetes and PAD, particularly those with concomitant polyvascular disease, are at a greater risk for future adverse cardiovascular and limb events.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
The Nexus of COPD, Cardiovascular Disease, and COVID-19: Key Strategies To Optimize Outcomes
Chronic obstructive pulmonary disease (COPD) is a chronic, complex disease with multiple systemic effects, including cardiometabolic conditions, which not only influence patient adherence by adding to the burden of pharmacotherapy, but may also impact COPD therapeutic decisions.
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Clinical Brief: Antithrombotic and Antiplatelet Therapy in the Cardiometabolic Patient
This clinical brief, adapted from a presentation at the 2021 CMHC Spring meeting, offers a concise overview of recent trials and developments in antithrombotic and antiplatelet therapy in high-risk cardiometabolic patients with coronary artery disease (CAD) or peripheral artery disease (PAD). 
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Virtual Symposium - The Nexus of Narcolepsy and Cardiometabolic Risk: Important Considerations and Implications for Management
Several cardiometabolic comorbidities, including overweight/obesity, dyslipidemia, cardiovascular diseases, hypertension, and type 2 diabetes or insulin resistance, are common in patients with narcolepsy.  Often these disorders are overlooked, but they have important implications in the managemen
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
Clinical Brief: Use of Insulin Pumps in the Management of Type 2 Diabetes: A Review of Guidelines and Evidence
This clinical brief, adapted from a presentation at the 2021 CMHC Spring meeting, offers an overview of insulin pumps and insulin delivery systems for T2DM, as well as expert feedback and practical strategies on how to integrate them to patient care.
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation
CMHC Masterclass On Demand: Addressing Cardiometabolic Risk in Children and Adolescents - Challenges and Solutions
The rapid rise of cardiometabolic disease and risk factors in children and adolescents is a huge cause of concern now and in the future.
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • CDE
  • Participation

Pages